Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Cardiovasc Res

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    March 2023
  1. VARDAS PE
    Large-scale digital population screening for atrial fibrillation: swinging around the uncertainties.
    Cardiovasc Res. 2023 Mar 3:cvad032. doi: 10.1093.
    PubMed    


    January 2023
  2. NINNI S, Nattel S
    Factor XIa inhibition in atrial fibrillation: insights and knowledge gaps emerging from the PACIFIC-AF trial.
    Cardiovasc Res. 2023 Jan 25:cvac196. doi: 10.1093.
    PubMed    


    December 2022
  3. GIACCA M
    Gene editing for cardiomyopathy takes a step forward.
    Cardiovasc Res. 2022;118:3011-3012.
    PubMed    


  4. SUFFEE N, Baptista E, Piquereau J, Ponnaiah M, et al
    Impacts of a high-fat diet on the metabolic profile and the phenotype of atrial myocardium in mice.
    Cardiovasc Res. 2022;118:3126-3139.
    PubMed     Abstract available


    October 2022
  5. TOW BD, Deb A, Neupane S, Patel SM, et al
    SR-Mitochondria Crosstalk Shapes Ca Signalling to Impact Pathophenotype in Disease Models Marked by Dysregulated Intracellular Ca Release.
    Cardiovasc Res. 2022;118:2819-2832.
    PubMed     Abstract available


    July 2022
  6. NYNS ECA, Jin T, Fontes MS, van den Heuvel T, et al
    Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.
    Cardiovasc Res. 2022;118:2293-2303.
    PubMed     Abstract available


  7. KEEFE J, Wehrens XH, Dobrev D
    Common disease-promoting signaling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences.
    Cardiovasc Res. 2022 Jul 5. pii: 6631397. doi: 10.1093.
    PubMed    


    June 2022
  8. CHAUMONT C, Suffee N, Gandjbakhch E, Balse E, et al
    Epicardial origin of cardiac arrhythmias: clinical evidences and pathophysiology.
    Cardiovasc Res. 2022;118:1693-1702.
    PubMed     Abstract available


  9. ALEXANDER C, Bishop MJ, Gilchrist RJ, MRes BA, et al
    Initiation of ventricular arrhythmia in the acquired long QT syndrome.
    Cardiovasc Res. 2022 Jun 21. pii: 6612700. doi: 10.1093.
    PubMed     Abstract available


  10. GAWALKO M, Saljic A, Li N, Abu-Taha I, et al
    Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance.
    Cardiovasc Res. 2022 Jun 11. pii: 6605797. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  11. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
    The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Cardiovasc Res. 2022;118:1466-1478.
    PubMed     Abstract available


    April 2022
  12. LIUTKUTE A, Brundel BJ, Voigt N
    Not the classical serendipity: does doxapram treat atrial fibrillation?
    Cardiovasc Res. 2022 Apr 15. pii: 6568887. doi: 10.1093.
    PubMed    


  13. FARINHA JM, Gupta D, Lip GYH
    Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation and stroke.
    Cardiovasc Res. 2022 Apr 7. pii: 6564589. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  14. YU JK, Liang JA, Franceschi WH, Huang Q, et al
    Assessment of arrhythmia mechanism and burden of the infarcted ventricles following remuscularization with pluripotent stem cell-derived cardiomyocyte patches using patient-derived models.
    Cardiovasc Res. 2022;118:1247-1261.
    PubMed     Abstract available


  15. PROIETTI R, Lip GYH, Akhtar R, Field M, et al
    Thoracic aortic aneurysms and atrial fibrillation: commonality in pathophysiological pathways.
    Cardiovasc Res. 2022;118:e32-e35.
    PubMed    


  16. LOUCH WE
    A TRP to the emergency room: Understanding arrhythmia in the ageing heart.
    Cardiovasc Res. 2022;118:932-933.
    PubMed    


  17. PEANA D, Polo-Parada L, Domeier TL
    Arrhythmogenesis in the aged heart following ischaemia-reperfusion: role of transient receptor potential vanilloid 4.
    Cardiovasc Res. 2022;118:1126-1137.
    PubMed     Abstract available


    January 2022
  18. MACIAS A, Diaz-Larrosa JJ, Blanco Y, Fanjul V, et al
    Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Cardiovasc Res. 2022;118:503-516.
    PubMed     Abstract available


  19. BARC J, Ravens U
    Scientists on the Spot: Tracing the potential in electrophysiology.
    Cardiovasc Res. 2022;118:e6-e7.
    PubMed    


  20. JAYARAM R, Jones M, Reilly S, Crabtree MJ, et al
    Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin.
    Cardiovasc Res. 2022;118:184-195.
    PubMed     Abstract available


  21. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Publisher's note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2022 Jan 5. pii: 6498023. doi: 10.1093.
    PubMed    


    December 2021
  22. RAVENS U, Gomez AM, Heijman J, Remme CA, et al
    Edward Carmeliet (1930-2021)-channelling scientific curiosity: a tribute from the ESC Working Group on Cardiac Cellular Electrophysiologydagger.
    Cardiovasc Res. 2021;117:e171-e173.
    PubMed    


  23. COPPINI R, Cerbai E
    Of hits, players, and goalkeepers: the case of arrhythmias in diabetes.
    Cardiovasc Res. 2021;117:2694-2695.
    PubMed    


  24. HATEM SN, Cohen A
    Atrial fibrillation and stroke: are we looking in the right direction?
    Cardiovasc Res. 2021 Dec 13. pii: 6460256. doi: 10.1093.
    PubMed    


    November 2021
  25. LI N, Durgan DJ, Wehrens XHT
    Gut microbiota - a key regulator of aging-associated atrial fibrillation?
    Cardiovasc Res. 2021 Nov 26. pii: 6443115. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  26. SANTEMA BT, Arita VA, Sama IE, Kloosterman M, et al
    Pathophysiological pathways in patients with heart failure and atrial fibrillation.
    Cardiovasc Res. 2021 Oct 23. pii: 6409189. doi: 10.1093.
    PubMed     Abstract available


  27. NI L, Lahiri SK, Nie J, Pan X, et al
    Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice.
    Cardiovasc Res. 2021 Oct 14. pii: 6396865. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  28. DOBREV D, Dudley SC
    Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?
    Cardiovasc Res. 2021;117:2291-2293.
    PubMed    


  29. GAWALKO M, Agbaedeng TA, Saljic A, Muller DN, et al
    Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.
    Cardiovasc Res. 2021 Sep 22. pii: 6373888. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  30. CAMPBELL H, Aguilar-Sanchez Y, Quick AP, Dobrev D, et al
    SPEG: a key regulator of cardiac calcium homeostasis.
    Cardiovasc Res. 2021;117:2175-2185.
    PubMed     Abstract available


  31. BALLOUZ S, Mangala MM, Perry MD, Heitmann S, et al
    Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
    Cardiovasc Res. 2021;117:2216-2227.
    PubMed     Abstract available


  32. DING WY, McDowell G, Lip GYH
    Utilising biomarkers in atrial fibrillation: the pros and cons.
    Cardiovasc Res. 2021 Aug 25. pii: 6357701. doi: 10.1093.
    PubMed    


  33. POL T, Hijazi Z, Lindback J, Oldgren J, et al
    Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Cardiovasc Res. 2021 Aug 6. pii: 6343453. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  34. HALL EJ, Pal S, Glennon MS, Shridhar P, et al
    Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.
    Cardiovasc Res. 2021 Jul 30. pii: 6332002. doi: 10.1093.
    PubMed     Abstract available


  35. AL SAYED ZR, Canac R, Cimarosti B, Bonnard C, et al
    Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Cardiovasc Res. 2021;117:2092-2107.
    PubMed     Abstract available


  36. BOUKENS BJD, Dacey M, Meijborg VMF, Janse MJ, et al
    Mechanism of ventricular premature beats elicited by left stellate ganglion stimulation during acute ischaemia of the anterior left ventricle.
    Cardiovasc Res. 2021;117:2083-2091.
    PubMed     Abstract available


  37. ALVAREZ-FRANCO A, Rouco R, Ramirez RJ, Guerrero-Serna G, et al
    Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression.
    Cardiovasc Res. 2021 Jul 13. pii: 6319837. doi: 10.1093.
    PubMed    


  38. DERI S, Borbas J, Hartai T, Hategan L, et al
    Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated from an Andersen-Tawil syndrome patient.
    Cardiovasc Res. 2021;117:1923-1934.
    PubMed     Abstract available


  39. RATHJENS FS, Blenkle A, Iyer LM, Renger A, et al
    Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.
    Cardiovasc Res. 2021;117:1908-1922.
    PubMed     Abstract available


  40. ZHAO Y, James NA, Beshay AR, Chang EE, et al
    Adult zebrafish ventricular electrical gradients as tissue mechanisms of ECG patterns under baseline vs. oxidative stress.
    Cardiovasc Res. 2021;117:1891-1907.
    PubMed     Abstract available


    June 2021
  41. SCHOTTEN U
    From translation to integration: how to approach the complexity of atrial fibrillation mechanisms.
    Cardiovasc Res. 2021;117:e88-e90.
    PubMed    


  42. SCOTT L JR, Fender AC, Saljic A, Li L, et al
    NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.
    Cardiovasc Res. 2021;117:1746-1759.
    PubMed     Abstract available


  43. HIRAM R, Xiong F, Naud P, Xiao J, et al
    The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Cardiovasc Res. 2021;117:1776-1789.
    PubMed     Abstract available


  44. BORIANI G, Vitolo M, Diemberger I, Proietti M, et al
    Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.
    Cardiovasc Res. 2021;117:1-21.
    PubMed     Abstract available


  45. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    PubMed     Abstract available


  46. NATTEL S, Lip GYH, Filgueiras-Rama D, Dobrev D, et al
    Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation.
    Cardiovasc Res. 2021 Jun 4. pii: 6292088. doi: 10.1093.
    PubMed    


    May 2021
  47. CASADEI B, Sipido KR
    Calcium and postoperative atrial fibrillation: round up the usual suspects!
    Cardiovasc Res. 2021 May 29. pii: 6288489. doi: 10.1093.
    PubMed    


  48. WIEDMANN F, Beyersdorf C, Zhou XB, Kraft M, et al
    Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.
    Cardiovasc Res. 2021 May 24. pii: 6283579. doi: 10.1093.
    PubMed     Abstract available


  49. HANNA P, Buch E, Stavrakis S, Meyer C, et al
    Neuroscientific Therapies for Atrial Fibrillation.
    Cardiovasc Res. 2021 May 14. pii: 6275748. doi: 10.1093.
    PubMed     Abstract available


  50. KANY S, Reissmann B, Metzner A, Kirchhof P, et al
    Genetics of atrial fibrillation - practical applications for clinical management: If not now, when and how?
    Cardiovasc Res. 2021 May 12. pii: 6274893. doi: 10.1093.
    PubMed     Abstract available


  51. OLIER I, Ortega-Martorell S, Pieroni M, Lip GYH, et al
    How machine learning is impacting research in atrial fibrillation: Implications for risk prediction and future management.
    Cardiovasc Res. 2021 May 12. pii: 6274894. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  52. HEIJMAN J, Sutanto H, Crijns HJGM, Nattel S, et al
    Computational models of atrial fibrillation: achievements, challenges and perspectives for improving clinical care.
    Cardiovasc Res. 2021 Apr 23. pii: 6247759. doi: 10.1093.
    PubMed     Abstract available


  53. HATEM SN
    Revealing the molecular history of the transition from paroxysmal to permanent atrial fibrillation.
    Cardiovasc Res. 2021 Apr 20. pii: 6241493. doi: 10.1093.
    PubMed    


    February 2021
  54. PROTONOTARIOS A, Marelli-Berg F
    Influenza-associated cardiac injury: a disease of the cardiac conduction system?
    Cardiovasc Res. 2021;117:643-644.
    PubMed    


  55. LEE YK, Sala L, Mura M, Rocchetti M, et al
    MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
    Cardiovasc Res. 2021;117:767-779.
    PubMed     Abstract available


    January 2021
  56. HEGYI B, Ko CY, Bossuyt J, Bers DM, et al
    Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycemia: reduced repolarization reserve, neurohormonal stimulation and heart failure exacerbate susceptibility.
    Cardiovasc Res. 2021 Jan 23. pii: 6105172. doi: 10.1093.
    PubMed     Abstract available


  57. RONCHI C, Bernardi J, Mura M, Stefanello M, et al
    NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Cardiovasc Res. 2021;117:472-483.
    PubMed     Abstract available


  58. GUICHARD JB, Xiong F, Qi XY, L'Heureux N, et al
    Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodelling.
    Cardiovasc Res. 2021;117:462-471.
    PubMed     Abstract available


    January 2020
  59. ZHANG D, Tu H, Wang C, Cao L, et al
    Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure.
    Cardiovasc Res. 2020 Jan 29. pii: 5717428. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: